Showing results (1791-1800 of 2,111) with videos related to
Sort By:
Pageof 212
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.Plant and Soil|April 19, 2019
Inter- and intra-species intercropping of barley cultivars and legume species, as affected by soil phosphorus availabilityTegan Darch, Courtney D Giles, Martin S A Blackwell, et al.Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2024
Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trialBrianna Lau, Yufan F Wu, Sunan Cui, et al.Biological Psychiatry Global Open Science|September 25, 2025
Epigenetic and Structural Brain Aging and Their Associations With Major Depressive DisorderEileen Y Xu, Claire Green, Daniel L McCartney, et al.Genes|October 27, 2020
Expression Quantitative Trait Locus Mapping in Pulmonary Arterial HypertensionAnna Ulrich, Pablo Otero-Núñez, John Wharton, et al.Nature|September 28, 2022
Universal control of a six-qubit quantum processor in siliconStephan G J Philips, Mateusz T Mądzik, Sergey V Amitonov, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.Neuroimage|September 5, 2018
Polygenic risk score for schizophrenia and structural brain connectivity in older age: A longitudinal connectome and tractography studyC Alloza, S R Cox, M Blesa Cábez, et al.American Journal of Respiratory and Critical Care Medicine|September 14, 2018
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary HypertensionDaniela Farkas, A A Roger Thompson, Aneel R Bhagwani, et al.Pageof 212